These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12532774)

  • 21. [Effect of high-frequency oscillation on hypoxic pulmonary vasoconstriction].
    Sugaya K; Watanabe S; Gao W
    Masui; 1989 Nov; 38(11):1492-7. PubMed ID: 2585718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxic pulmonary vasoconstriction: a multifactorial response?
    Weissmann N; Grimminger F; Olschewski A; Seeger W
    Am J Physiol Lung Cell Mol Physiol; 2001 Aug; 281(2):L314-7. PubMed ID: 11435204
    [No Abstract]   [Full Text] [Related]  

  • 23. Selective protein kinase C inhibition attenuates pulmonary artery cytokine expression without affecting hypoxic pulmonary vasoconstriction.
    Tsai BM; Patel K; Wang M; Morrell ED; Crisostomo PR; Meldrum DR
    Shock; 2007 Jan; 27(1):36-9. PubMed ID: 17172978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mechanism of hypoxic pulmonary vasoconstriction].
    Okada O; Kuriyama T
    Nihon Naika Gakkai Zasshi; 1991 Nov; 80(11):1826-32. PubMed ID: 1664443
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypoxia and the pulmonary circulation: a brief review.
    Barer GR
    Z Erkr Atmungsorgane; 1989; 173(2):109-15. PubMed ID: 2686219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric oxide (NO)-dependent but not NO-independent guanylate cyclase activation attenuates hypoxic vasoconstriction in rabbit lungs.
    Weissmann N; Voswinckel R; Tadic A; Hardebusch T; Ghofrani HA; Schermuly RT; Seeger W; Grimminger F
    Am J Respir Cell Mol Biol; 2000 Aug; 23(2):222-7. PubMed ID: 10919989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular remodeling versus vasoconstriction in chronic hypoxic pulmonary hypertension: a time for reappraisal?
    Stenmark KR; McMurtry IF
    Circ Res; 2005 Jul; 97(2):95-8. PubMed ID: 16037575
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of pentose phosphate pathway-derived NADPH in hypoxic pulmonary vasoconstriction.
    Gupte SA; Okada T; McMurtry IF; Oka M
    Pulm Pharmacol Ther; 2006; 19(4):303-9. PubMed ID: 16203165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pulmonary interstitial compartment and the mediator of hypoxic pulmonary vasoconstriction.
    Benumof JL; Mathers JM; Wahrenbrock EA
    Microvasc Res; 1978 Jan; 15(1):69-75. PubMed ID: 634158
    [No Abstract]   [Full Text] [Related]  

  • 30. Differing effects of acute and prolonged alkalosis on hypoxic pulmonary vasoconstriction.
    Gordon JB; Martinez FR; Keller PA; Tod ML; Madden JA
    Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1651-6. PubMed ID: 8256915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance imaging of uneven pulmonary perfusion in hypoxia in humans.
    Dehnert C; Risse F; Ley S; Kuder TA; Buhmann R; Puderbach M; Menold E; Mereles D; Kauczor HU; Bärtsch P; Fink C
    Am J Respir Crit Care Med; 2006 Nov; 174(10):1132-8. PubMed ID: 16946125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basic features of hypoxic pulmonary vasoconstriction in mice.
    Weissmann N; Akkayagil E; Quanz K; Schermuly RT; Ghofrani HA; Fink L; Hänze J; Rose F; Seeger W; Grimminger F
    Respir Physiol Neurobiol; 2004 Jan; 139(2):191-202. PubMed ID: 15123002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Selective inhibition of hypoxic pulmonary vasoconstriction by inhibition of cytochrome oxidase (author's transl)].
    Hara N; Yoshida T; Said SI
    Nihon Kyobu Shikkan Gakkai Zasshi; 1979 Mar; 17(3):161-5. PubMed ID: 221712
    [No Abstract]   [Full Text] [Related]  

  • 34. Hydralazine does not inhibit canine hypoxic pulmonary vasoconstriction.
    Bishop MJ; Kennard S; Artman LD; Cheney FW
    Am Rev Respir Dis; 1983 Dec; 128(6):998-1001. PubMed ID: 6650991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in smooth muscle cell pH during hypoxic pulmonary vasoconstriction: a possible role for ion transporters.
    Madden JA; Keller PA; Kleinman JG
    Physiol Res; 2000; 49(5):561-6. PubMed ID: 11191360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxic pulmonary vasoconstriction is/is not mediated by increased production of reactive oxygen species.
    Evans AM; Gonzalez C
    J Appl Physiol (1985); 2006 Sep; 101(3):1001-2; author reply 1004-5. PubMed ID: 16969920
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypoxic pulmonary vasoconstriction is/is not mediated by increased production of reactive oxygen species.
    Gupte SA; Wolin MS
    J Appl Physiol (1985); 2006 Sep; 101(3):1000-1; author reply 1004-5. PubMed ID: 16969918
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypoxic pulmonary vasoconstriction is/is not mediated by increased production of reactive oxygen species.
    Berchner-Pfannschmidt U; Acker H; Fandrey J
    J Appl Physiol (1985); 2006 Sep; 101(3):1000; author reply 1004-5. PubMed ID: 16969917
    [No Abstract]   [Full Text] [Related]  

  • 39. Carbon monoxide inhibits hypoxic pulmonary vasoconstriction in rats by a cGMP-independent mechanism.
    Tamayo L; López-López JR; Castañeda J; González C
    Pflugers Arch; 1997 Nov; 434(6):698-704. PubMed ID: 9306001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxic pulmonary vasoconstriction is/is not mediated by increased production of reactive oxygen species.
    Packer CS; Pelaez NJ
    J Appl Physiol (1985); 2006 Sep; 101(3):1001; author reply 1004-5. PubMed ID: 16969919
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.